149 related articles for article (PubMed ID: 36513143)
1. State of the art and perspectives in pediatric hepatocellular carcinoma.
Digiacomo G; Serra RP; Turrini E; Tiri A; Cavazzoni A; Alfieri R; Bertolini P
Biochem Pharmacol; 2023 Jan; 207():115373. PubMed ID: 36513143
[TBL] [Abstract][Full Text] [Related]
2. Sorafenib in pediatric hepatocellular carcinoma from a clinician perspective.
Pearson H; Marshall LV; Carceller F
Pediatr Hematol Oncol; 2020 Aug; 37(5):412-423. PubMed ID: 32183592
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and toxicity of cisplatin and doxorubicin (PLADO) in childhood hepatoblastoma and hepatocellular carcinoma: a SIOP pilot study.
Ninane J; Perilongo G; Stalens JP; Guglielmi M; Otte JB; Mancini A
Med Pediatr Oncol; 1991; 19(3):199-203. PubMed ID: 1850817
[TBL] [Abstract][Full Text] [Related]
4. Etoposide, cisplatin, epirubicin chemotherapy in the treatment of pediatric liver tumors.
Casanova M; Massimino M; Ferrari A; Spreafico F; Piva L; Coppa J; Luksch R; Cefalo G; Terenziani M; Polastri D; Bellani FF; Mazzaferro V
Pediatr Hematol Oncol; 2005; 22(3):189-98. PubMed ID: 16020101
[TBL] [Abstract][Full Text] [Related]
5. Fibrolamellar hepatocellular carcinoma in children and adolescents.
Katzenstein HM; Krailo MD; Malogolowkin MH; Ortega JA; Qu W; Douglass EC; Feusner JH; Reynolds M; Quinn JJ; Newman K; Finegold MJ; Haas JE; Sensel MG; Castleberry RP; Bowman LC
Cancer; 2003 Apr; 97(8):2006-12. PubMed ID: 12673731
[TBL] [Abstract][Full Text] [Related]
6. [Results of the HB-89 Study in treatment of malignant epithelial liver tumors in childhood and concept of a new HB-94 protocol].
von Schweinitz D; Bürger D; Bode U; Weinel P; Erttmann R; Hecker H; Mildenberger H
Klin Padiatr; 1994; 206(4):282-8. PubMed ID: 7526028
[TBL] [Abstract][Full Text] [Related]
7. Pediatric Hepatocellular Carcinoma.
Varol Fİ
J Gastrointest Cancer; 2020 Dec; 51(4):1169-1175. PubMed ID: 32856229
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology group.
Czauderna P; Mackinlay G; Perilongo G; Brown J; Shafford E; Aronson D; Pritchard J; Chapchap P; Keeling J; Plaschkes J; Otte JB;
J Clin Oncol; 2002 Jun; 20(12):2798-804. PubMed ID: 12065556
[TBL] [Abstract][Full Text] [Related]
9. [Surgical strategy in pediatric liver malignancies].
von Schweinitz D; Fuchs J; Mildenberger H
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():1091-4. PubMed ID: 9101788
[TBL] [Abstract][Full Text] [Related]
10. Sorafenib and cisplatin/doxorubicin (PLADO) in pediatric hepatocellular carcinoma.
Schmid I; Häberle B; Albert MH; Corbacioglu S; Fröhlich B; Graf N; Kammer B; Kontny U; Leuschner I; Scheel-Walter HG; Scheurlen W; Werner S; Wiesel T; von Schweinitz D
Pediatr Blood Cancer; 2012 Apr; 58(4):539-44. PubMed ID: 21922643
[TBL] [Abstract][Full Text] [Related]
11. Pilot study of the combination of sorafenib and fractionated irinotecan in pediatric relapse/refractory hepatic cancer (FINEX pilot study).
Keino D; Yokosuka T; Hirose A; Sakurai Y; Nakamura W; Fujita S; Hayashi A; Miyagawa N; Iwasaki F; Hamanoue S; Yanagimachi M; Shiomi M; Goto S; Kitagawa N; Tanaka M; Nozawa K; Tanaka Y; Goto H
Pediatr Blood Cancer; 2020 Nov; 67(11):e28655. PubMed ID: 32798298
[TBL] [Abstract][Full Text] [Related]
12. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group.
Schnater JM; Aronson DC; Plaschkes J; Perilongo G; Brown J; Otte JB; Brugieres L; Czauderna P; MacKinlay G; Vos A
Cancer; 2002 Feb; 94(4):1111-20. PubMed ID: 11920482
[TBL] [Abstract][Full Text] [Related]
13. Clinical heterogeneity of pediatric hepatocellular carcinoma.
D'Souza AM; Towbin AJ; Gupta A; Alonso M; Nathan JD; Bondoc A; Tiao G; Geller JI
Pediatr Blood Cancer; 2020 Jun; 67(6):e28307. PubMed ID: 32307899
[TBL] [Abstract][Full Text] [Related]
14. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
Häberle B; Bode U; von Schweinitz D
Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children's Cancer Group intergroup study.
Katzenstein HM; Krailo MD; Malogolowkin MH; Ortega JA; Liu-Mares W; Douglass EC; Feusner JH; Reynolds M; Quinn JJ; Newman K; Finegold MJ; Haas JE; Sensel MG; Castleberry RP; Bowman LC
J Clin Oncol; 2002 Jun; 20(12):2789-97. PubMed ID: 12065555
[TBL] [Abstract][Full Text] [Related]
16. Pediatric hepatocellular carcinoma: challenges and solutions.
Schmid I; von Schweinitz D
J Hepatocell Carcinoma; 2017; 4():15-21. PubMed ID: 28144610
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein modulation improves in vitro chemosensitivity in malignant pediatric liver tumors.
Warmann S; Göhring G; Teichmann B; Geerlings H; Pietsch T; Fuchs J
Anticancer Res; 2003; 23(6C):4607-11. PubMed ID: 14981903
[TBL] [Abstract][Full Text] [Related]
18. Clear cell hepatocellular carcinoma arising 25 years after the successful treatment of an infantile hepatoblastoma.
Basile J; Caldwell S; Nolan N; Hammerle C
Ann Hepatol; 2010; 9(4):465-7. PubMed ID: 21057168
[TBL] [Abstract][Full Text] [Related]
19. Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults.
Sumazin P; Peters TL; Sarabia SF; Kim HR; Urbicain M; Hollingsworth EF; Alvarez KR; Perez CR; Pozza A; Najaf Panah MJ; Epps JL; Scorsone K; Zorman B; Katzenstein H; O'Neill AF; Meyers R; Tiao G; Geller J; Ranganathan S; Rangaswami AA; Woodfield SE; Goss JA; Vasudevan SA; Heczey A; Roy A; Fisher KE; Alaggio R; Patel KR; Finegold MJ; López-Terrada DH
J Hepatol; 2022 Oct; 77(4):1026-1037. PubMed ID: 35577029
[TBL] [Abstract][Full Text] [Related]
20. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group.
Ortega JA; Krailo MD; Haas JE; King DR; Ablin AR; Quinn JJ; Feusner J; Campbell JR; Lloyd DA; Cherlow J
J Clin Oncol; 1991 Dec; 9(12):2167-76. PubMed ID: 1720452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
